Gold tier: mechanically validated evidence, with its primary source.
682 evidence items · page 16 / 28
The percentage of men with sickle cell disease who had erectile dysfunction was more than twofold higher than that of men without sickle cell disease who had erectile dysfunction.
Nigeriadrépanocytosepublished 2020Blood advancesPubMeddocument of 5 observations
6.5 %The prevalence of cholelithiasis was 6.5% in younger children with sickle cell disease.
Nigeriacholelithiasis · drépanocytosepublished 2022Annals of African medicinePubMeddocument of 6 observations
1.21 %The estimated average birth prevalence of HbSS in Nigeria was 1.21%.
Nigeriadrépanocytosepublished 2021The Lancet. Haematologyeurope_pmcdocument of 6 observations
50 %In the phase 2 portion of the RISE UP trial, the haemoglobin response rate (≥1.0 g/dL increase from baseline in average haemoglobin concentration from week 10 through week 12) was 50% in the mitapivat 100 mg group.
Nigeriadrépanocytosepublished 2025The Lancet. Haematologyeurope_pmcdocument of 9 observations
58.3 %Sixty participants with SCA had 58.3% females and a mean age of 24.77 ± 7.39 years.
Nigeriadrépanocytoseobserved 2020-12-02 to 2021-03-31published 2022The Pan African medical journalPubMeddocument of 4 observations
442 patientsSouth registered 442 patients with sickle cell disease, representing 5.7% of the total enrolled in Nigeria.
Nigeriadrépanocytosepublished 2022Frontiers in geneticseurope_pmcdocument of 8 observations
92 %The acceptance of newborn screening for sickle cell disease was high, at 718 (92%) among the 780 mothers.
Nigeriadrépanocytosepublished 2023West African journal of medicinePubMeddocument of 5 observations
43 patients43 of the males had priapism.
Nigeriadrépanocytosepublished 2021Hematology (Amsterdam, Netherlands)PubMeddocument of 16 observations
116 patientsHydroxyurea was administered to 116 patients aged 1.2–17 years at a mean dose of 18.5 ± 4.3 mg/kg/day over 33 months.
Nigeriadrépanocytosepublished 2021Pediatric blood & cancereurope_pmcdocument of 10 observations
2 deathsA total of 2 deaths occurred in the low-dose hydroxyurea group.
Nigeriadrépanocytosepublished 2023BloodPubMeddocument of 8 observations
1.4 %Among 17 newborns with sickle cell disease (HbSS and HbSC) identified in The Gambia, 6 (1.4%) were from the Mandinka ethnic group.
Nigeriadrépanocytosepublished 2024Hemoglobineurope_pmcdocument of 10 observations
1 %Among 490 analysed alleles from 245 homozygous sickle cell disease patients in Nigeria, five (1.0%) had the Bantu/Central African Republic haplotype.
Nigeriadrépanocytosepublished 2021The Journal of international medical researchPubMeddocument of 5 observations
22.4 %Pack cell volume (PCV) in steady state subjects was 22.4 ± 2.7.
Nigeriadrépanocytosepublished 2022The Pan African medical journalPubMeddocument of 14 observations
1 %The public health department had the least proportion of sickle cell disease cases at 1%.
Nigeriadrépanocytoseobserved 2013 to 2014published 2022The Pan African medical journalPubMeddocument of 9 observations
47.2 %The prevalence of albuminuria was 47.2% among patients with sickle cell disease in Ahmadu Bello University Teaching Hospital, Zaria.
NigeriadrépanocytosePubMeddocument of 7 observations
XO level was significantly higher in the HbS group than in the control group.
Nigeriadrépanocytosepublished 2025Sultan Qaboos University medical journalPubMeddocument of 5 observations
40 patientsForty of the 85 SCA patients had urine specific gravity below 1.010.
Nigeriadrépanocytosepublished 2023Malawi medical journal : the journal of Medical Association of MalawiPubMeddocument of 12 observations
Weight and body mass index (BMI) were significantly lower in children with sickle cell anaemia compared to controls (p = 0.010 and p = 0.029 respectively).
Nigeriadrépanocytosepublished 2024West African journal of medicinePubMeddocument of 9 observations
71 %Among 172 children with sickle cell disease, 71% (122/172) were on regular blood transfusion.
Nigeriadrépanocytosepublished 2022British journal of haematologyPubMeddocument of 7 observations
4.8 %Among 3622 enrolled sickle cell disease patients in Nigeria, 4.8% had experienced priapism.
Nigeriadrépanocytose · priapismpublished 2020Blood cells, molecules & diseaseseurope_pmcdocument of 16 observations
23.5 %The spleen was visualised in 23.5% of patients aged 15 years and older with sickle cell disease.
Nigeriadrépanocytosepublished 2023Tropical medicine & international health : TM & IHPubMeddocument of 6 observations
3.8 %The population prevalence of sickle cell disease (SCD) in the study was 3.8%.
Nigeriadrépanocytosepublished 2025West African journal of medicinePubMeddocument of 8 observations
67.1 %Two-thirds of the study participants (67.1%) indicated that they would prioritise sickle cell screening in their relationships.
Nigeriadrépanocytosepublished 2022Hematology (Amsterdam, Netherlands)PubMeddocument of 6 observations
5 x10⁹/LAbsolute lymphocyte count in crisis state subjects was 5.0 ± 1.3.
Nigeriadrépanocytosepublished 2022The Pan African medical journalPubMeddocument of 14 observations
8.8 yearsThe mean age of the cases was 8.8 years with a standard deviation of 3.2 years.
Nigeriadrépanocytosepublished 2023Ghana medical journalPubMeddocument of 7 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.